XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue Interest Purchase Agreement - Additional Information (Details) - Purchase Agreement - OrbiMed - USD ($)
3 Months Ended 6 Months Ended
Sep. 12, 2022
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Upfront payment received $ 125,000,000      
Potential revenue interest second payment to be received $ 75,000,000      
Purchase agreement, second payment date Sep. 12, 2025      
Potential revenue interest third payment to be received $ 50,000,000      
Purchase agreement, third payment date Sep. 12, 2025      
Revenue interest payment term 45 days      
Amortization of purchase agreement obligation       $ 0
Effective interest rate   11.40%   11.40%
Debt issuance costs   $ 600,000   $ 600,000
Revenue interest payable   $ 2,446,000 $ 1,883,000 $ 2,400,000
Maximum        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Potential revenue interest payment to be received $ 125,000,000